JPH0534338B2 - - Google Patents

Info

Publication number
JPH0534338B2
JPH0534338B2 JP57143398A JP14339882A JPH0534338B2 JP H0534338 B2 JPH0534338 B2 JP H0534338B2 JP 57143398 A JP57143398 A JP 57143398A JP 14339882 A JP14339882 A JP 14339882A JP H0534338 B2 JPH0534338 B2 JP H0534338B2
Authority
JP
Japan
Prior art keywords
acid
poly
active ingredient
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57143398A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5933222A (ja
Inventor
Shizuo Shimada
Osamu Yano
Junichi Furukawa
Etsuro Kuramoto
Haruo Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Priority to JP14339882A priority Critical patent/JPS5933222A/ja
Publication of JPS5933222A publication Critical patent/JPS5933222A/ja
Publication of JPH0534338B2 publication Critical patent/JPH0534338B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP14339882A 1982-08-20 1982-08-20 合成デオキシリボ核酸を有効成分とする抗腫瘍剤 Granted JPS5933222A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14339882A JPS5933222A (ja) 1982-08-20 1982-08-20 合成デオキシリボ核酸を有効成分とする抗腫瘍剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14339882A JPS5933222A (ja) 1982-08-20 1982-08-20 合成デオキシリボ核酸を有効成分とする抗腫瘍剤

Publications (2)

Publication Number Publication Date
JPS5933222A JPS5933222A (ja) 1984-02-23
JPH0534338B2 true JPH0534338B2 (en, 2012) 1993-05-21

Family

ID=15337834

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14339882A Granted JPS5933222A (ja) 1982-08-20 1982-08-20 合成デオキシリボ核酸を有効成分とする抗腫瘍剤

Country Status (1)

Country Link
JP (1) JPS5933222A (en, 2012)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10590384B2 (en) 2014-01-14 2020-03-17 Luterion Co., Ltd. Luterial and method for isolating and culturing the same
US10624926B2 (en) 2014-01-14 2020-04-21 Luterion Co., Ltd. Luterial and method for isolating and culturing the same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2156289C (en) * 1993-02-19 2006-01-03 Junichi Yano Drug composition containing nucleic acid copolymer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57145815A (en) * 1981-03-04 1982-09-09 Sanraku Inc Antitumor agent
JPS5855499A (ja) * 1981-09-28 1983-04-01 Sanraku Inc 抗腫瘍性を有する変性デオキシリボ核酸の製法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10590384B2 (en) 2014-01-14 2020-03-17 Luterion Co., Ltd. Luterial and method for isolating and culturing the same
US10624926B2 (en) 2014-01-14 2020-04-21 Luterion Co., Ltd. Luterial and method for isolating and culturing the same

Also Published As

Publication number Publication date
JPS5933222A (ja) 1984-02-23

Similar Documents

Publication Publication Date Title
Davies et al. Misoprostol therapeutics revisited
US4393071A (en) Method of treating gastric, mammary, lung and uterus tumors
SK137996A3 (en) Cancer treatment and metastasis prevention
US6063814A (en) Phorbol esters as anti-neoplastic and white blood cell elevating agents
JP2714402B2 (ja) 癌転移抑制剤
JP3041232B2 (ja) 癌転移抑制剤
JP2706371B2 (ja) 癌治療用補助剤及びそれを用いたキット
WO2014128429A1 (fr) Hétérocycles phosphorés analogues de sucres à activité antimétastatique
JPS6328045B2 (en, 2012)
JPH0534338B2 (en, 2012)
JPH07116031B2 (ja) 制癌剤
NL194430C (nl) Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking.
WO1992011247A1 (en) Anticancer composition and compound
BG107806A (bg) Състав, включващ камптотецинови и стилбенови производни, за лечение на рак
EA004570B1 (ru) Применение производного антрациклина для лечения опухоли печени
WO2001000217A1 (fr) Compositions medicinales de prevention ou de traitement de la diarrhee
JPS6016926A (ja) 抗腫瘍剤
JPH08165236A (ja) 下痢の予防及び治療剤
JPS5927326B2 (ja) 抗腫瘍活性を有する薬剤組成物
HRESHCHYSHYN A critical review of chemotherapy in the treatment of ovarian carcinoma
JPH0211513A (ja) 制癌剤
Killen et al. Phase II studies of methyl glyoxal bis‐guanylhydrazone (NSC 32946) in carcinoma of the colon and lung
OZAWA et al. Pharmacological properties of heterocyclic amidine derivatives. II. Pharmacological studies of phenylguanylpiperazine derivatives
US20040121991A1 (en) Dehydroepiandrosterone (DHEA) congeners for prevention and/or treatment of ulcers
JPH0120128B2 (en, 2012)